Delivery Order SPE2DB20D3103-SPE2DB25FQ1F9
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,488.21 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-unit supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Qulipta is a psychiatric medication used in the treatment of bipolar disorder and other...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets in a quantity of 30 units, valued at $7,459.83. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1.75K to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract valued at $1,649.05. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen will perform this contract from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,481.34 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count supply) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,373.74 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $4,755.64 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Qulipta 60 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,568.63. This non-set-aside competitive award is scheduled for completion by September 2, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $13,955.02 to AmerisourceBergen Drug Corp for 30-count tablets of Qulipta 60 mg, a pharmaceutical product used in neurological treatment applications. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded on August 15, 2025. No set-aside designation was used for this competitive award. Performance will occur at AmerisourceBergen's corporate office in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,694.51, is for the delivery of 4,568,104,420 units of the medication Qulipta 60 mg tablet. The contract has a firm fixed price and is not a set-aside procurement. It has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...